Pilot research projects
Our commitment to research sees us partner with the University of Aberdeen, Robert Gordon University and NHS Grampian to fund pioneering studies that improve our understanding and treatment of cancers and haematological illnesses.
Since 2010, we have funded 72 oncology and haematology pilot research projects, at a cost of up to £15,000 per study.
We provide this level of support to help grow the foundations of our knowledge of cancer and haematological diseases, to produce initial data to attract large-scale research funding and to attract and retain top clinicians and researchers to the North-east, and ultimately, to benefit those who receive treatment in the ANCHOR Unit, now and in the future.
Over
0
invested into pilot research
Oncology research cancer types
Bowel
Brain
Breast
Colorectal
Effects of chemotherapy
Gastric
Brain
Breast
Colorectal
Effects of chemotherapy
Gastric
Head/neck
Leukaemia
Lung
Lymphoma
Muscle
Neutropenic sepsis
Leukaemia
Lung
Lymphoma
Muscle
Neutropenic sepsis
Oral
Ovarian
Pancreas
Prostate
Skin
Ovarian
Pancreas
Prostate
Skin
Haematology research
Haemorrhage
Myeloproliferative Disease
Myeloproliferative Disease
Sickle Cell Anaemia
Thrombosis
Thrombosis
Research targets
A spectrum of research aims have been supported, ranging from enhanced understanding of disease biology, through improved diagnostic and disease monitoring approaches, to novel potential treatments.
7 currently supported projects...
The oro-intestinal microbiota as a novel marker for early detection and a target for prevention of oral cancer
Project
Disease Type: Oral cancer
Research Target: Underpinning biology; Treatment targets; Biological markers
Lead Researcher: Karolin Hijazi
Location: University of Aberdeen
Funding: £14,973
Research Target: Underpinning biology; Treatment targets; Biological markers
Lead Researcher: Karolin Hijazi
Location: University of Aberdeen
Funding: £14,973
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients

Analysing the dynamic changes of the microbiota along the length of the colin: a comparison of the gut
Project
Disease Type: Colon cancer
Research Target: Underpinning biology, Biological markers, New technology
Lead Researcher: Mr George Ramsay
Location: University of Aberdeen
Funding: £13,679
Research Target: Underpinning biology, Biological markers, New technology
Lead Researcher: Mr George Ramsay
Location: University of Aberdeen
Funding: £13,679
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients

Unravelling the thrombotic complications associated with sickle cell disease
Project
Disease Type: Blood disorders - sickle cell disease
Research Target: Underpinning biology; Treatment targets; New technology
Lead Researcher: Dr Nicola Mutch
Location: University of Aberdeen
Funding: £15,000
Research Target: Underpinning biology; Treatment targets; New technology
Lead Researcher: Dr Nicola Mutch
Location: University of Aberdeen
Funding: £15,000
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients

Salmonella Toxin: A New Cancer Therapeutic Tool
Project
Disease Type: Oncology
Research Target: Underpinning biology; Treatment targets; Imaging markers
Lead Researcher: Dr Sergio Dall'Angelo
Location: University of Aberdeen
Funding: £9,770
Research Target: Underpinning biology; Treatment targets; Imaging markers
Lead Researcher: Dr Sergio Dall'Angelo
Location: University of Aberdeen
Funding: £9,770
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients

Can malignant and benign breast cancer be differentiated by radiological microcalcification classification
Project
Disease Type: Breast cancer
Research Target: New technology; imaging markers
Lead Researcher: Dr Jiabao He
Location: University of Aberdeen
Funding: £14,663
Research Target: New technology; imaging markers
Lead Researcher: Dr Jiabao He
Location: University of Aberdeen
Funding: £14,663
Background
Aims and research undertaken
Benefit to future ANCHOR Unit patients
